# Reversibility of Cardiac Conduction Disturbances Following TAVI

> **NCT06481137** · NA · RECRUITING · sponsor: **Institut d'Investigació Biomèdica de Bellvitge** · enrollment: 209 (estimated)

## Conditions studied

- Aortic Stenosis
- Transcatheter Aortic Valve Implantation
- Conduction Disturbances

## Interventions

- **DIAGNOSTIC_TEST:** Electrophysiological study (EP study)
- **DIAGNOSTIC_TEST:** ePatch (extended Holter Monitoring)

## Key facts

- **NCT ID:** NCT06481137
- **Lead sponsor:** Institut d'Investigació Biomèdica de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-17
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 209 (ESTIMATED)
- **Last updated:** 2024-07-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06481137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06481137, "Reversibility of Cardiac Conduction Disturbances Following TAVI". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06481137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*